| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 33,248,000 | 25,346,000 | 30,582,000 | 44,381,000 | | Cost of Revenue | 2,848,000 | 20,271,000 | (11,495,000) | 11,495,000 | | | Gross Profit | 30,400,000 | 5,075,000 | 42,077,000 | 32,886,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,492,000 | 22,694,000 | 14,631,000 | 15,567,000 | | Non Recurring | 735,000 | 1,787,000 | 8,000 | (44,000) | | Others | 9,915,000 | 22,597,000 | 10,698,000 | 19,917,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,258,000 | (42,003,000) | 16,740,000 | (2,554,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,258,000 | (42,003,000) | 16,740,000 | (2,554,000) | | Interest Expense | 4,863,000 | (9,613,000) | 23,900,000 | 1,928,000 | | Income Before Tax | 2,395,000 | (32,390,000) | (7,160,000) | (4,482,000) | | Income Tax Expense | 785,000 | (10,975,000) | (3,417,000) | (2,329,000) | | Minority Interest | 16,000 | 309,000 | 95,000 | (76,000) | | | | Net Income From Continuing Ops | 1,626,000 | (21,106,000) | (3,648,000) | (2,229,000) | | | Non-recurring Events | | Discontinued Operations | (33,000) | 3,843,000 | 833,000 | (266,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,593,000 | (17,263,000) | (2,815,000) | (2,495,000) | | Preferred Stock And Other Adjustments | (2,559,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($966,000) | ($17,263,000) | ($2,815,000) | ($2,495,000) |
|
3.07% Nasdaq 
Income Statement
